By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bexion Pharmaceuticals 

632 Russell St.

Covington  Kentucky  41011  U.S.A.
Phone: 001-859-757-1652 Fax: 001-859-581-3900



Company News
Bexion Pharmaceuticals And CTI - Clinical Trial and Consulting Services Announce Completion Of First-In-Human Trial Using BXQ-350 For The Treatment Of Cancer 9/6/2017 11:22:53 AM
Bexion Pharmaceuticals Doses First Patient In Phase I Trial Of BXQ-350 For Patients With Advanced Solid Tumors At The University Of Cincinnati Cancer Institute 9/20/2016 8:13:34 AM
Bexion Pharmaceuticals Receives FDA Clearance For The First Clinical Trial Using BXQ-350 To Dose Patients With Cancer 7/18/2016 7:26:35 AM
Bexion Pharmaceuticals Wins 2015 Tibbetts Award From The Small Business Administration 6/1/2015 11:31:50 AM
Bexion Pharmaceuticals Receives Orphan Drug Designation For Saposin C, The Active Ingredient In BXQ-350 For Glioblastoma Multiforme From FDA 2/16/2015 11:42:40 AM
Bexion Pharmaceuticals Awarded $2.9MM SBIR Bridge Award by National Cancer Institute to Support Phase I First-in-Human Clinical Trial in Cancer 10/14/2013 8:38:34 AM
Bexion Pharmaceuticals Receives Outstanding Biotech Innovation Award 4/19/2011 7:54:59 AM
Booming Jobs in Biotech/Med Device Companies, Including Bexion Pharmaceuticals and Medpace, Inc., Despite Recession 3/18/2011 12:17:41 PM
Former FDA Commissioner Joins Bexion Pharmaceuticals Board 1/6/2011 7:07:00 AM